Novo Holdings A/S - Q1 2014 holdings

Add to watchlist

$1.6 Billion is the total value of Novo Holdings A/S's 14 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 37.5% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
VTI  VANGUARD INDEX FDStotal stk mkt$580,746,000
+1.6%
5,958,2000.0%36.24%
-15.0%
OPHT  OPHTHOTECH CORP$492,541,000
+10.3%
13,807,3080.0%30.74%
-7.8%
VGK  VANGUARD INTL EQUITY INDEX Fftse europe etf$249,708,000
+1.1%
4,202,0000.0%15.58%
-15.5%
INGN NewINOGEN INC$178,950,000–10,838,898
+100.0%
11.17%–
FLXN NewFLEXION THERAPEUTICS INC$58,666,000–3,566,262
+100.0%
3.66%–
T107PS  WRIGHT MED GROUP INC$18,200,000
+1.2%
585,7590.0%1.14%
-15.4%
TTPH SellTETRAPHASE PHARMACEUTICALS INC$9,801,000
-39.6%
900,000
-25.0%
0.61%
-49.5%
SellTETRAPHASE PHARMACEUTICALS INC$9,801,000
-39.6%
900,000
-25.0%
0.61%
-49.5%
WMGIZ  WRIGHT MED GROUP INCright 03/01/2019$3,918,000
+156.9%
4,720,0650.0%0.24%
+114.9%
PTCT ExitPTC THERAPEUTICS INC$0–-1,194,718
-100.0%
-1.71%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2014-11-14
  • View 13F-HR filed 2014-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VANGUARD INDEX FDS41Q3 202264.7%
INOGEN INC34Q2 202268.8%
VANGUARD INTL EQUITY INDEX F29Q4 201637.6%
AMICUS THERAPEUTICS INC22Q3 20234.1%
AKEBIA THERAPEUTICS INC21Q3 20204.8%
VERONA PHARMA PLC21Q2 20221.9%
CORVUS PHARMACEUTICALS INC20Q4 20207.1%
INSPIRE MED SYS INC20Q3 20231.8%
CABLE ONE INC19Q3 20239.7%
FLEXION THERAPEUTICS INC19Q3 20214.7%

View Novo Holdings A/S's complete holdings history.

Latest significant ownerships (13-D/G)
Novo Holdings A/S Q1 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cyteir Therapeutics, Inc.August 03, 20231,547,1364.4%
Disc Medicine, Inc.June 28, 20231,090,7724.8%
Galera Therapeutics, Inc.June 28, 20232,100,0004.9%
VectivBio Holding AGSold outMay 26, 202300.0%
LanzaTech Global, Inc.February 17, 202315,814,8458.1%
Bolt Biotherapeutics, Inc.Sold outJanuary 04, 202300.0%
Arcellx, Inc.December 12, 20221,750,0004.0%
MINERVA SURGICAL INCNovember 03, 20221,322,4734.5%
Milestone Pharmaceuticals Inc.October 24, 20221,378,5384.6%
Galecto, Inc.September 30, 20222,497,7919.8%

View Novo Holdings A/S's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
42024-05-14
SC 13G/A2024-05-14
1442024-05-10
SC 13D/A2024-03-28
42024-03-25
SC 13D/A2024-03-25
42024-03-20
SC 13D/A2024-03-20
1442024-03-18

View Novo Holdings A/S's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1600331000.0 != 1602331000.0)
  • The reported has been amended

Export Novo Holdings A/S's holdings

CSVXLS